EFAX ETF Analysis

Cette page a été traduite automatiquement de l'original anglais par IA ; la version anglaise fait foi. Lire la version anglaise

À titre informatif uniquement. Ne constitue pas un conseil financier.

Réponse Rapide

EFAX ETF has a last stored price of $53.68, as of the Oct 5, 2026 trading session. Holdings and weights below are as of Mar 15, 2026.

In the stored portfolio snapshot, the largest listed holding is ASML Holding NV (ASML.AS) at 2.74%.

EFAX ETF — Price, Holdings & Analysis

Vue d'ensemble de l'ETF

EFAX aims to provide investors with a focused approach to international equity exposure. Unlike broad-based international ETFs that may hold hundreds or thousands of stocks, EFAX invests. This strategy allows for potentially higher returns if the selected companies outperform, but it also introduces greater risk due to the lack of diversification. The fund's holdings are primarily large-cap companies based in Europe and Asia, including ASML Holding NV (2.74%), Roche Holding AG (1.62%), and AstraZeneca PLC (1.57%). This concentrated approach may appeal to investors seeking targeted exposure to specific international companies, but it is important to consider the increased volatility associated with a less diversified portfolio. EFAX's strategy is distinct from market-cap weighted international ETFs, which typically offer broader diversification across a larger number of holdings.

Mesures de Risque

EFAX's concentrated portfolio introduces significant concentration risk. A substantial portion of the fund's assets is allocated to a small number of companies, meaning that the performance of these companies will have a disproportionate impact on the fund's overall returns. The fund's beta of 1.02 indicates that it has a slightly higher volatility than the market. Investors should also consider the potential impact of currency fluctuations on the fund's returns, as the underlying holdings are denominated in various foreign currencies. Past performance does not guarantee future results.

Bêta: 1.02

Que détient EFAX ?

Participation	Pondération
ASML Holding NV (ASML.AS)	2.74%
Roche Holding AG (ROG.SW)	1.62%
AstraZeneca PLC (AZN.L)	1.57%
Novartis AG Registered Shares (NOVN.SW)	1.56%
HSBC Holdings PLC (HSBA.L)	1.56%
Nestle SA (NESN.SW)	1.36%
Toyota Motor Corp (7203.T)	1.13%
Siemens AG (SIE.DE)	1.07%
Mitsubishi UFJ Financial Group Inc (8306.T)	1.06%
SAP SE (SAP.DE)	1.02%

Positions et pondérations au 15 mars 2026. Ces données du fonds datent de plus de 45 jours ; vérifiez les positions actuelles auprès de l’émetteur.

Rendement du Dividende

0.00%

Questions & Réponses

What is EFAX and what does it track?

EFAX is an exchange-traded fund that provides concentrated exposure to a small selection of international equities. Unlike many ETFs that track broad market indexes, EFAX.

This focused approach aims to deliver potentially higher returns by concentrating investments in a select group of companies.

What are the top holdings in EFAX?

EFAX's top holdings include ASML Holding NV (2.74%), Roche Holding AG (1.62%), and AstraZeneca PLC (1.57%). These companies represent a significant portion of the fund's total assets.

The fund's concentration in these top holdings means that their individual performance will have a notable impact on the overall performance of EFAX. Investors should research these companies to understand their businesses and assess their potential for future growth.

Is EFAX a good long-term investment?

Whether EFAX is a suitable long-term investment depends on an individual investor's risk tolerance and investment objectives. The fund's concentrated portfolio introduces a higher level of risk compared to more diversified ETFs.

The fund's beta of 1.02 suggests it may be slightly more volatile than the overall market. Investors should carefully consider these factors and their own investment goals before investing in EFAX. Past performance does not guarantee future results.

How does EFAX compare to similar ETFs?

EFAX distinguishes itself from similar ETFs through its highly. Most international equity ETFs hold a much larger number of companies to achieve broader diversification. This concentrated approach can lead to higher potential returns but also greater volatility.

Without expense ratio information, it's difficult to compare the cost-effectiveness of EFAX to its peers.

Does EFAX pay dividends?

According to the provided data, EFAX has a dividend yield of 0.00%. This indicates that the fund does not currently distribute dividends to its shareholders.

Investors seeking income from their investments may want to consider other ETFs with higher dividend yields. However, it is important to note that dividend yields can fluctuate over time and are not guaranteed.

Avertissement : Ce contenu est fourni à titre informatif uniquement et ne constitue pas un conseil en investissement. Effectuez toujours vos propres recherches et consultez un conseiller financier.

Données fournies à titre informatif uniquement.

Rédigé par une machine, sans relecture page par page. Le contrôle éditorial est systémique : les règles et les sources sont vérifiées, pas chaque page.